95 research outputs found
Servant Leadership as a Framework for Building University Community: The Intersecting Missions of Faith Partners and Public Higher Education Institutions
As community engagement approaches continue to expand in urban-identified public colleges and universities, so have innovative community-university partnerships that now span a wide range of public and private sector organizations. Partnerships between public universities and faith-based institutions, however, have sometimes lagged because public universities have yet to appreciate ways in which their public missions align with those of local faith-based organizations. This paper examines the partnership established between a large, urban-identified, public research university and one of its campus ministries to implement a servant leadership model and asset-based community development methodology designed to enable the university community to work collaboratively, recognize their own and others’ gifts and talents, and improve their own broadly-defined diverse communities. This research shows that through a servant leadership framework, faith can inform and enact this public mission to create active and engaged citizens. The asset-based partnership model shows promise for realizing the intersecting missions of faith partners and public higher education institutions, which can be replicated in with other institutions
pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.
We present case histories of four patients treated with artemether-lumefantrine for falciparum malaria in UK hospitals in 2015 to 2016. Each subsequently presented with recurrent symptoms and Plasmodium falciparum parasitemia within 6 weeks of treatment with no intervening travel to countries where malaria is endemic. Parasite isolates, all of African origin, harbored variants at some candidate resistance loci. No evidence of pfk13-mediated artemisinin resistance was found. Vigilance for signs of unsatisfactory antimalarial efficacy among imported cases of malaria is recommended
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
Background. Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed to HIV-1
via breastfeeding reduces transmission through this route compared with single-dose nevirapine at birth or neonatally.
We aimed to assess incremental safety and efficacy of extension of such prophylaxis to 6 months.
Methods In our phase 3, randomised, double-blind, placebo-controlled HPTN 046 trial, we assessed the incremental
benefit of extension of once-daily infant nevirapine from age 6 weeks to 6 months. We enrolled breastfeeding infants
born to mothers with HIV-1 in four African countries within 7 days of birth. Following receipt of nevirapine from
birth to 6 weeks, infants without HIV infection were randomly allocated (by use of a computer-generated permuted
block algorithm with random block sizes and stratified by site and maternal antiretroviral treatment status) to receive
extended nevirapine prophylaxis or placebo until 6 months or until breastfeeding cessation, whichever came first.
The primary efficacy endpoint was HIV-1 infection in infants at 6 months and safety endpoints were adverse reactions
in both groups. We used Kaplan-Meier analyses to compare differences in the primary outcome between groups.
This study is registered with ClinicalTrials.gov, number NCT00074412.
Findings. Between June 19, 2008, and March 12, 2010, we randomly allocated 1527 infants (762 nevirapine and
765 placebo); five of whom had HIV-1 infection at randomisation and were excluded from the primary analyses. In
Kaplan-Meier analysis, 1·1% (95% CI 0·3–1·8) of infants who received extended nevirapine developed HIV-1 between
6 weeks and 6 months compared with 2·4% (1·3–3·6) of controls (difference 1·3%, 95% CI 0–2·6), equating to a
54% reduction in transmission (p=0·049). However, mortality (1·2% for nevirapine vs 1·1% for placebo; p=0·81) and
combined HIV infection and mortality rates (2·3% vs 3·2%; p=0·27) did not differ between groups at 6 months.
125 (16%) of 758 infants given extended nevirapine and 116 (15%) of 761 controls had serious adverse events, but
frequency of adverse events, serious adverse events, and deaths did not differ significantly between treatment groups.
Interpretation. Nevirapine prophylaxis can safely be used to provide protection from mother-to-child transmission of
HIV-1 via breastfeeding for infants up to 6 months of age
Environmentalism, pre-environmentalism, and public policy
In the last decade, thousands of new grassroots groups have formed to oppose environmental pollution on the basis that it endangers their health. These groups have revitalized the environmental movement and enlarged its membership well beyond the middle class. Scientists, however, have been unable to corroborate these groups' claims that exposure to pollutants has caused their diseases. For policy analysts this situation appears to pose a choice between democracy and science. It needn't. Instead of evaluating the grassroots groups from the perspective of science, it is possible to evaluate science from the perspective of environmentalism. This paper argues that environmental epidemiology reflects ‘pre-environmentalist’ assumptions about nature and that new ideas about nature advanced by the environmental movement could change the way scientists collect and interpret data.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/45449/1/11077_2005_Article_BF01006494.pd
Factors influencing the establishment of 'Mott' dwarf napiergrass
Due to the character of the original source materials and the nature of batch digitization, quality control issues may be present in this document. Please report any quality issues you encounter to [email protected], referencing the URI of the item.Includes bibliographical references.Not availabl
Recommended from our members
Persistence of Imported Malaria Into the United Kingdom: An Epidemiological Review of Risk Factors and At-risk Groups.
BACKGROUND: The United Kingdom documented a decline of >30% in imported cases of malaria annually between 1996 and 2003; however, there are still approximately 1700 cases and 5-10 deaths each year. Prophylaxis health messages focus on families returning to their country of origin. METHODS: We reviewed 225 records of patients seen in Cambridge University Hospital Foundation Trust [CUHFT], a tertiary referral center in Cambridge, England. All records of patients seen in CUHFT between 2002-2016 were analyzed in the context of national figures from Public Health England. RESULTS: Between 2004-2016, there was no decrease in imported cases of malaria locally or nationally. Plasmodium falciparum remains responsible for most imported infections (66.7%); Plasmodium vivax contributed 15.1%, Plasmodium malariae 4%, and Plasmodium ovale 6.7%; 7.5% (17/225) of patients had an incomplete record. Most cases were reported in people coming from West Africa. Sierra Leone and the Ivory Coast had the highest proportions of travelers being infected at 8 and 7 per 1000, respectively. Visiting family in the country of origin (27.8%) was the commonest reason for travel. However, this was exceeded by the combined numbers traveling for business and holidays (22.5% and 20.1%, respectively). Sixty percent of patients took no prophylaxis. Of those who did, none of the patients finished their chemoprophylaxis regimen. CONCLUSIONS: Significant numbers of travelers to malarious countries still take no chemoprophylaxis. Health advice about prophylaxis before travel should be targeted not only at those visiting family in their country of origin but also to those traveling for holiday and work
- …